Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3934279 | 1.00 | MEN1 (0.37) | MEN1MAPTHTTKMT2ASMN1; SMN2 | |
| SCHEMBL3931417 | 0.88 | MEN1 (0.39) | MEN1MAPTHTTKMT2ASMN1; SMN2 | |
| SCHEMBL3931412 | 0.88 | MEN1 (0.39) | MEN1MAPTHTTKMT2ASMN1; SMN2 | |
| Iodide SCHEMBL5918845 | 0.87 | MEN1 (0.40) | MEN1MAPTHTTKMT2ASMN1; SMN2 | |
| SCHEMBL13098676 | 0.83 | MEN1 (0.38) | MEN1MAPTHTTKMT2ASMN1; SMN2 | |
| SCHEMBL3934123 | 0.81 | RAB9A (0.38) | MEN1MAPTHTTKMT2ASMN1; SMN2 | |
| SCHEMBL26392086 | 0.81 | RAB9A (0.38) | MEN1MAPTHTTKMT2ASMN1; SMN2 | |
| SCHEMBL3934125 | 0.81 | RAB9A (0.38) | MEN1MAPTHTTKMT2ASMN1; SMN2 | |
| Iodide SCHEMBL5918651 | 0.80 | MEN1 (0.38) | MEN1MAPTHTTKMT2ASMN1; SMN2 | |
| SCHEMBL3933698 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1609459-B1 | Use of polycationic compounds for dyeing keratinous fibers | OREAL (FR) | 2009-04-08 | — | — | EP | disclosed |
| US-20060162098-A1 | Use of polycationic compounds for dyeing keratin fibres | L'OREAL S.A. (FR) | 2006-07-27 | — | — | US | disclosed |
| EP-1609459-A1 | Use of polycationic compounds for dyeing keratinous fibers | L'OREAL (FR) | 2005-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060162098-A1 | Use of polycationic compounds for dyeing keratin fibres | KRT18, DSG1, DSP | MEN1 2885/4885MAPT 250/4885HTT 1629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.